Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

RNA transcription modulator AU-409

An orally bioavailable RNA transcription modulator, with potential antineoplastic activity. Upon oral administration, RNA transcription modulator AU-409 specifically modulates transcription of RNA and affects the expression of certain genes that play a key role in cancer cell proliferation. This may inhibit tumor cell proliferation of susceptible tumor cells.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	AU 409 AU-409 AU409

RNA transcription modulator AU-409

Search NCI's Drug Dictionary